es sollte die grosse Hoffnung für Thailand sein - die Völkerfreundschaft mit China,
doch seit man nach der Machtablösung von Yingluck die Thailand-freundlichen Ansprechpartner in China in den Korruptionsverdacht rückte, hat sich durch den Wechsel der Aussenpolitik das Verhältnis China - Thailand tatsächlich verändert,
doch nicht in der gewünschten Richtung, denn die jetzigen Gesprächspartner erwarten in periodischen Abständen von Thailand den kotau, den sie nicht bekommen.
So ist schliesslich die grosse Einführung des Impfstoffes von Sinovac in Thailand, ins STocken geraten.
Wie ist das Verhältnis von Thailand zu Indien ?
Für den nationalistischen Teil der Bevölkerung, werden Produkte aus Indien mit dreckig assoziiert,
also nichts, zu dem man Vertrauen entwickelt.
Da besteht ein echtes Problem.
Was war in der Zwischenzeit passiert ?
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Derweil wird man in Thailand nervös,
....................................................................................................................................................................................
Siam Bioscience
invited the British-Swedish pharmaceutical group AstraZeneca
to visit its plant to see whether it met the criteria required to produce the vaccine at a minimum of 200 million doses per year. The government approved 600 million baht to improve the plant's facilities to produce the Covid-19 vaccine according to the requirements of AstraZeneca.
Many countries approached AstraZeneca to obtain the rights to produce the Covid-19 vaccine,
but the company selected Siam Bioscience as its partner to produce the vaccine for other countries in the region because it trusts Siam Bioscience, he said adding that the contract was signed under not-for-profit principles.
"
If the company wasn't set up under the late King Rama IX's initiative 10 years ago, we would not have this today. Please be confident that Thai people can access the vaccine," he said.
PM vows action against 'false' stories on vaccine plan
man würde also den ehemaligen König beleidigen, wenn man etwas gegen die Fabrik sagen würde.
Das Problem nur,
die New York Times berichtete unlängst, das Astra Zeneka in Indien produzieren lässt.
The Serum Institute says it is on track to increase production of the vaccine, which is known as Covishield in India. With $270 million of its own funds and
$300 million from the Bill and Melinda Gates Foundation, Serum plans to ramp up manufacturing capacity to 100 million doses per month by February, said Mayank Sen, a company spokesman.
From ‘Alma’ to ‘Zuri,’ Parents Are Looking for Positive Baby Names
Initially, the
Serum Institute signed a pact with
AstraZeneca to make one billion doses of the vaccine for low-and-middle-income countries. The vaccine holds appeal to developing countries because it is cheaper to make and easier to transport than those that require colder temperatures during storage and transportation.
The Serum Institute hit production delays as it built new facilities to make the vaccine. It says it
has already produced between 40 million and 50 million doses for the world. The company’s chief executive, Adar Poonawalla, told reporters on Monday that a majority of the doses would be given to India.
India Approves Oxford-AstraZeneca Covid-19 Vaccine and 1 Other
es sind also bekannte Mitteilungen, man hätte die Erlaubnis, für die Welt zu produzieren,
man hat sehr viel von eigenen Mittel investiert, um die Fabrik auszurichten, usw.
Doch offenbar, und das wäre dann an die Adresse von Thailand anzumerken,
reicht es nicht aus,
eine Fabrik umzurüsten, und zu sagen, Astra Zeneka möge sie besuchen, ob sie geeignet sei,
denn in dem Deal mit Astra Zeneka wird stehen,
die Fabrik muss das Serum produzieren und an die WHO übermitteln,
damit DIE feststellen, ob es zum Global Use geeignet ist.
.......................................................................................................................................................................................
NEW DELHI : Pune-based Serum Institute of India’s (SII)
Covishield vaccine developed by Oxford University and AstraZeneca, which recently got Indian drug regulator’s nod for use in covid-19 vaccination drive in India, may also get a green signal for global use from the World Health Organisation (WHO).
The global public health agency has indicated that it is looking forward to SII’s full data sets for rapid assessment to consider it for emergency use globally.
“We look forward to Serum Institute of India submitting full data sets for rapid assessment so WHO can determine
whether we can recommend their AstraZeneca vaccine for international use,"
said Tedros Adhanom Ghebreyesus, director general of the WHO during a press conference on Monday.
Serum Institute’s Covishield vaccine may be recommended for international use
davon scheint man in Thailand noch nichts gehört zu haben, ev. hat man den Deal anders verstanden ???
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
nun gut, mittlerweile war klar, dass die Produktion von Astra Zeneca in Thailand noch sehr sehr sehr weit entfernt ist,
sodass man für den Beginn der Impfung nun irgendwie Impfstoff herbeschaffen muss,
denn es ist ja eine WHO Vorgabe, dass im Februar weltweit die Impfungen beginnen sollen.
Derweil lief die Impfung in Indien mit dem selbst produzierten Astra Zeneca Impfstoff sehr gut an.
India started its immunisation programme on Jan. 16, with healthcare workers and a target of reaching 300 million people by July-August.
The world’s most populous country after China has vaccinated around 3.5 million healthcare workers in the first two weeks of the campaign.
A year after COVID-19's arrival, India's active cases fall
also,
wenn Thailand nun Impfstoff von Astra Zeneca braucht, warum sollte nicht das Serum Institute in Indien, den Impfstoff für Thailand produzieren ?
Doch die heutige meldung verwirrt uns.
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
The British/Swedish pharmaceutical company AstraZeneca will ship 150,000 doses of Covid-19 vaccines to Thailand from a manufacturing plant based in Asia, rather than from Italy, in a bid to ensure no delivery delays, the government said on Thursday.
The announcement was relayed by Public Health Minister, Anutin Charnvirakul, who said AstraZeneca sent a letter on Wednesday explaining the steps it will take to avoid disruptions to vaccine deliveries to Thailand, following the European Union's decision to temporarily suspend vaccine exports from the bloc.
That said, the minister stopped short of confirming the exact date when the vaccines are due to arrive in the country.
The letter, Mr Anutin said, also urged the government to approve the licences and permits required to import the vaccines, as they will now come from Asia rather than Europe.
This is important as AstraZeneca was only approved by the Thai Food and Drugs Administration (FDA) to import Covid-19 vaccines from its manufacturing facilities in Europe.
Some 50,000 doses of the vaccines will be on their way to Thailand soon under this licence -- however, the 150,000 doses which are scheduled to arrive in March and April will now be produced in Asia, as the EU moved to protect its own vaccine supplies by halting exports outside the region.
"We have put our best efforts in to secure vaccines, and we are expecting good news to come shortly," Mr Anutin said.
"If we get it, it will allow us to test our vaccine distribution network.
"Anyway, even if we don't get it, it won't have an impact on our plan to give 26 million doses of Covid-19 vaccines to Thais in June," he said, adding the need for vaccines isn't as urgent as before, as the outbreak in Samut Sakhon has been brought largely under control.
The Public Health Ministry has secured an additional 35 million doses from AstraZeneca, which means the government now has 61 million doses in total, enough to inoculate just over 30 million Thais as planned, Mr Anutin said.
While Siam Bioscience is expected to eventually produce AstraZeneca's vaccine locally under a technology-transfer agreement, Mr Anutin said it is AstraZeneca's responsibility to ensure Thailand gets the vaccines it had bought, regardless of where they were produced.
"We have signed a contract with AstraZeneca for at least 61 million doses, not with Siam Bioscience. If Siam Bioscience's plant can't produce the vaccine, it means nothing to us. This is because the purchase agreement clearly stated that AstraZeneca will provide the vaccine, not Siam Bioscience," he stressed.
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
AstraZeneca to send Covid jabs from Asia
so, so,
der thailändische Gesundheitsminister sagt, die Lieferungen kommen von einer Fabrik aus Asien,
welches Land ist bitteschön "Asien", gehört da dann auch ... indien ... dazu ?
wird es denn sauber sein ? ... also, bevor die Frage aufkommt, lassen wir die Fabrik in Asien.
... und das Thema Sinovac aus China ? ... kein Wort
Covid-19: 45% of health workers vaccinated in 18 days, India fastest to reach 4m mark | India News - Times of India
